Steven Fishbane, Jeffrey S. Berns, M.D. Kidney International

Slides:

Advertisements

Similar presentations

Hypothesis: an erythropoietin honeymoon phase exists

Advertisements

Volume 59, Issue 3, Pages (March 2001)

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Beta blockers in the management of chronic kidney disease

Iron status and iron supplementation in peritoneal dialysis patients

Recalcitrant pain in a patient with ADPKD

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 83, Issue 3, Pages (March 2013)

Red blood cell life span and ‘erythropoietin resistance’

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Volume 64, Pages S3-S12 (December 2003)

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

Volume 75, Issue 11, Pages (June 2009)

Volume 62, Issue 2, Pages (August 2002)

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Steven J. Chadban, Natalie D. Staplin Kidney International

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Darbepoetin alfa: A new therapeutic agent for renal anemia

Volume 70, Issue 11, Pages (December 2006)

Joseph W. Eschbach, John W. Adamson Kidney International

Body weight is a fluctuating parameter in hemodialysis patients

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

This Month in AJKD American Journal of Kidney Diseases

Nephrology Crosswords: Hemodialysis

Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover.

Study of Heart and Renal Protection (SHARP)

Volume 60, Issue 6, Pages (December 2001)

Volume 86, Issue 1, Pages (July 2014)

Nephrology Crossword: History of nephrology

Kenar D. Jhaveri, Steven Fishbane Kidney International

Blood pressure targets in hemodialysis patients

Volume 78, Issue 2, Pages (July 2010)

Volume 75, Issue 11, Pages (June 2009)

A physician's perseverance uncovers problems in a key nephrology study

Effects of hemodialysis on cardiac function

Francesco Locatelli, Lucia Del Vecchio Kidney International

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 79, Issue 3, Pages (February 2011)

Alternate-day dialysis may be needed for hemodialysis patients

Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients Bernard G. Jaar, Brad C. Astor, Jeffrey S.

Simvastatin in nephrotic syndrome

Nephrology Crossword: Glomerulonephritis

Terry Behrend, Steven B. Miller, M.D Kidney International

A man with a hole in his penis

Hemoglobin variability in epoetin-treated hemodialysis patients

Daily nocturnal home hemodialysis

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Carmine Zoccali, Francesca Mallamaci Kidney International

Current status of maintenance hemodialysis in Beijing, China

Organ transplantation goes to the movies

Volume 70, Pages S84-S90 (November 2006)

Volume 64, Issue 3, Pages (September 2003)

Volume 70, Issue 8, Pages (October 2006)

Volume 66, Issue 6, Pages (December 2004)

Volume 63, Issue 3, Pages (March 2003)

Volume 80, Issue 10, Pages (November 2011)

Volume 64, Issue 5, Pages (November 2003)

Charles A. Herzog Kidney International

Volume 70, Issue 3, Pages (August 2006)

Volume 62, Issue 6, Pages (December 2002)

Volume 70, Issue 5, Pages (September 2006)

Changes to the End-Stage Renal Disease Quality Incentive Program

Volume 59, Issue 3, Pages (March 2001)

Strategies for iron supplementation: Oral versus intravenous

The International Pediatric Peritonitis Registry: Starting to walk

Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis Karl-Georg Fischer, M.D., Andreas van.

Stephen Pastan, J. Michael Soucie, William M. McClellan

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin Steven Fishbane, Jeffrey S. Berns, M.D. Kidney International Volume 68, Issue 3, Pages 1337-1343 (September 2005) DOI: 10.1111/j.1523-1755.2005.00532.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Distribution of the number of recombinant human erythropoietin (rHuEPO) dose changes per patient in 1 year. Kidney International 2005 68, 1337-1343DOI: (10.1111/j.1523-1755.2005.00532.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 A graphic example of hemoglobin (Hgb) cycling in a 59-year-old diabetic man, showing both hemoglobin and recombinant human erythropoietin (rHuEPO) dose. Kidney International 2005 68, 1337-1343DOI: (10.1111/j.1523-1755.2005.00532.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Distribution of the number of hemoglobin excursions per patient in 1 year. Kidney International 2005 68, 1337-1343DOI: (10.1111/j.1523-1755.2005.00532.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Distribution of hemoglobin (Hgb) amplitude for all hemoglobin excursions. The amplitude is the difference between hemoglobin level at the beginning and end of an excursion. Kidney International 2005 68, 1337-1343DOI: (10.1111/j.1523-1755.2005.00532.x) Copyright © 2005 International Society of Nephrology Terms and Conditions